Allergan to Buy Back Up to $10 Billion in Shares

Allergan Plc, the maker of the anti-wrinkle injection Botox, said it will buy back as much as $10 billion in stock following its failed union with Pfizer Inc.

Allergan expects to execute $4 billion to $5 billion in open market repurchases over four to six months subject to favorable market conditions, the company said today in a statement.

Link to Statement:Link

Before it's here, it's on the Bloomberg Terminal.